Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 8/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 4/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | METAP2 | P50579 | 1/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23774157 | 0.97 | GRM5 (0.35) | GRM5L3MBTL1HTR1AHTR7KDM4E | |
| SCHEMBL18958449 | 0.97 | GRM5 (0.36) | GRM5L3MBTL1HTR1AHTR7KDM4E | |
| SCHEMBL18958465 | 0.97 | GRM5 (0.36) | GRM5L3MBTL1HTR1AHTR7KDM4E | |
| SCHEMBL18958734 | 0.94 | NPY5R (0.36) | GRM5L3MBTL1HTR1AHTR7KDM4E | |
| SCHEMBL17349353 | 0.94 | NPY5R (0.36) | GRM5L3MBTL1HTR1AHTR7KDM4E | |
| SCHEMBL18958448 | 0.94 | TOP1 (0.37) | GRM5L3MBTL1KDM4EATMALDH1A1 | |
| SCHEMBL18958463 | 0.94 | TOP1 (0.37) | GRM5L3MBTL1KDM4EATMALDH1A1 | |
| SCHEMBL18958458 | 0.93 | L3MBTL1 (0.37) | GRM5L3MBTL1KDM4EATMALDH1A1 | |
| SCHEMBL17349389 | 0.93 | L3MBTL1 (0.37) | GRM5L3MBTL1KDM4EATMALDH1A1 | |
| SCHEMBL18958384 | 0.93 | GRM5 (0.37) | GRM5L3MBTL1HTR1AHTR7KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170170407-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20170170407-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD (KR) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170170407-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | OR10J3, OR51E2, ETV6 | GRM5 2484/4885L3MBTL1 1793/4885HTR1A 4779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.